RhumbLine Advisers’s Viela Bio, Inc. Common Stock VIE Stock Holding History

RhumbLine Advisers’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,932	Closed	-$933K	–	3043
2020 Q4	$933K	Buy	25,932 +1,893	+8%	+$66.3K	﹤0.01%	2164
2020 Q3	$675K	Sell	24,039 -3,080	-11%	-$109K	﹤0.01%	2155
2020 Q2	$1.18M	Buy	27,119 +20,897	+336%	+$946K	﹤0.01%	1977
2020 Q1	$236K	Buy	+6,222	New	+$243K	﹤0.01%	2512

RhumbLine Advisers's VIE Position: Q1 2021 in Review

RhumbLine Advisers sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 25,932 shares — an estimated $933K sold.

RhumbLine Advisers first reported a position in VIE in Q1 2020 and held it in 4 quarters. The position peaked at $1.18M in Q2 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

RhumbLine Advisers reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
RhumbLine Advisers sold 25,932 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $933K.
RhumbLine Advisers first reported a position in Viela Bio, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
RhumbLine Advisers's Viela Bio, Inc. Common Stock position peaked at $1.18M in Q2 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.